Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary changes induced by amphophilic drugs.

Z Hruban

    Environmental Health Perspectives
    |August 1, 1976
    PubMed
    Summary

    Amphophilic drugs cause phospholipidosis, a lysosomal disease, by altering phospholipids. This leads to myeloid bodies and foamy macrophages in lungs, impairing cellular digestion and metabolism.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Haematopoietic malignancies in zoo animals.

    Journal of comparative pathology·1992
    Same author

    Nonlysosomal cytoplasmic degradation.

    Journal of submicroscopic cytology and pathology·1991
    Same author

    Globular changes in cytomegaloviral inclusions after Ganciclovir treatment.

    Archives of virology·1989
    Same author

    Diffuse nodular hyperplasia and fibrosis of the liver in lead-poisoned mandrills.

    Journal of medical primatology·1986
    Same author

    Aortic dissection in a gorilla.

    Journal of medical primatology·1986
    Same author

    Pulmonary and generalized lysosomal storage induced by amphiphilic drugs.

    Environmental health perspectives·1984

    Area of Science:

    • Cell Biology
    • Toxicology
    • Pharmacology

    Background:

    • Amphophilic drugs can induce cellular changes in experimental animals.
    • These changes include myeloid body formation and foamy macrophage accumulation.
    • Pulmonary alveolar proteinosis is a known consequence.

    Purpose of the Study:

    • To elucidate the mechanism by which amphophilic drugs cause phospholipidosis.
    • To understand the cellular and molecular basis of drug-induced lysosomal disorders.
    • To investigate the link between drug-phospholipid interactions and observed pathologies.

    Main Methods:

    • Administration of amphophilic drugs to experimental animal models.
    • Cellular analysis to identify morphological changes, including myeloid body formation.
    • Histopathological examination of pulmonary tissues to assess macrophage accumulation and alveolar proteinosis.

    Main Results:

    • Amphophilic drugs interact with phospholipids, altering their physicochemical properties.
    • Impaired digestion of altered pulmonary secretions in macrophages leads to foam cell accumulation.
    • Disrupted metabolism of phospholipids via autophagy results in myeloid body accumulation.

    Conclusions:

    • Administration of amphophilic compounds induces a generalized phospholipidosis, a drug-induced lysosomal disease.
    • The findings highlight the critical role of phospholipid metabolism and lysosomal function in drug toxicity.
    • Understanding these mechanisms is crucial for predicting and mitigating drug-induced cellular damage.

    Related Experiment Videos